Total Payments
$16,628
2024 Payments
$411.22
Companies
19
Transactions
73
Medicare Patients
8,792
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$7,837 (47.1%)
Consulting$3,939 (23.7%)
Travel$2,800 (16.8%)
Food & Beverage$2,025 (12.2%)
Education$26.70 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,838 | 2 | 47.1% |
| Consulting Fee | $3,939 | 3 | 23.7% |
| Travel and Lodging | $2,800 | 10 | 16.8% |
| Food and Beverage | $2,025 | 56 | 12.2% |
| Education | $26.70 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $12,911 | 18 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $1,300 | 1 | $0 (2021) |
| Boston Scientific Corporation | $1,102 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $409.04 | 6 | $0 (2024) |
| Abbott Laboratories | $139.13 | 1 | $0 (2018) |
| Amgen Inc. | $127.43 | 9 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $123.73 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $120.98 | 3 | $0 (2023) |
| PFIZER INC. | $90.82 | 7 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $58.60 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $411.22 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($264.28) |
| 2023 | $38.62 | 2 | Novo Nordisk Inc ($22.63) |
| 2022 | $35.00 | 2 | Merck Sharp & Dohme LLC ($21.70) |
| 2021 | $1,441 | 3 | Biohaven Pharmaceuticals, Inc. ($1,300) |
| 2020 | $11.86 | 1 | PFIZER INC. ($11.86) |
| 2019 | $4,678 | 6 | Daiichi Sankyo Inc. ($4,640) |
| 2018 | $5,807 | 16 | Daiichi Sankyo Inc. ($4,737) |
| 2017 | $4,205 | 39 | Daiichi Sankyo Inc. ($3,534) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: DIABETES | ||||||
| 04/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $146.94 | General |
| Category: General - Therapies_CRM | ||||||
| 04/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: DIABETES | ||||||
| 02/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: DIABETES | ||||||
| 10/10/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/07/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2021 | Biohaven Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 01/09/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/28/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,037.50 | General |
| Category: Anemia | ||||||
| 03/25/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Travel and Lodging | In-kind items and services | $65.24 | General |
| Category: Anemia | ||||||
| 03/20/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Travel and Lodging | In-kind items and services | $536.85 | General |
| Category: Anemia | ||||||
| 02/19/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: STRUCTURAL HEART | ||||||
| 02/14/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/23/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Travel and Lodging | Cash or cash equivalent | $73.22 | General |
| Category: STRUCTURAL HEART | ||||||
| 10/23/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/15/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $266.37 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/14/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Travel and Lodging | In-kind items and services | $461.35 | General |
| Category: STRUCTURAL HEART | ||||||
| 08/24/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Travel and Lodging | In-kind items and services | $108.00 | General |
| Category: Anemia | ||||||
| 08/17/2018 | Abbott Laboratories | Mitra Clip system (Device) | Consulting Fee | Cash or cash equivalent | $139.13 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,233 | 3,577 | $385,118 | $276,172 |
| 2022 | 17 | 2,247 | 3,652 | $390,495 | $274,293 |
| 2021 | 18 | 2,150 | 3,573 | $392,447 | $277,082 |
| 2020 | 17 | 2,162 | 3,461 | $353,739 | $248,537 |
Total Patients
8,792
Total Services
14,263
Medicare Billing
$1.1M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 986 | $141,077 | $101,088 | 71.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 274 | 278 | $63,694 | $47,853 | 75.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 106 | 106 | $55,203 | $43,814 | 79.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 99 | 99 | $21,978 | $17,235 | 78.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 77 | 79 | $17,891 | $13,573 | 75.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 148 | $15,000 | $11,034 | 73.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 332 | 773 | $12,709 | $9,347 | 73.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 41 | 161 | $9,866 | $7,151 | 72.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 119 | 121 | $9,791 | $6,742 | 68.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 32 | $6,404 | $4,582 | 71.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 101 | 101 | $3,535 | $3,431 | 97.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 418 | 492 | $17,220 | $3,229 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $4,652 | $2,977 | 64.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 101 | 101 | $3,535 | $2,212 | 62.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 22 | 49 | $1,976 | $1,551 | 78.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 13 | $349.96 | $224.18 | 64.1% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 13 | $238.16 | $127.05 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 310 | 983 | $142,361 | $98,499 | 69.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 104 | 106 | $58,161 | $45,370 | 78.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 242 | 246 | $58,482 | $43,822 | 74.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 104 | 106 | $23,532 | $18,584 | 79.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 67 | 71 | $16,621 | $13,000 | 78.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 145 | $14,908 | $10,969 | 73.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 323 | 756 | $12,503 | $8,797 | 70.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 40 | 164 | $10,200 | $7,946 | 77.9% |
About Dr. Gary Berman, MD
Dr. Gary Berman, MD is a Cardiovascular Disease healthcare provider based in West Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609981281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Berman, MD has received a total of $16,628 in payments from pharmaceutical and medical device companies, with $411.22 received in 2024. These payments were reported across 73 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,838).
As a Medicare-enrolled provider, Berman has provided services to 8,792 Medicare beneficiaries, totaling 14,263 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location West Orange, NJ
- Active Since 08/21/2006
- Last Updated 11/01/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609981281
Products in Payments
- INJECTAFER (Drug) $12,891
- WATCHMAN (Device) $849.61
- JARDIANCE (Drug) $389.07
- Mitra Clip system (Device) $139.13
- XARELTO (Drug) $123.73
- FARXIGA (Drug) $120.98
- GENERAL - THERAPIES (Device) $104.96
- Corlanor (Drug) $100.23
- Edarbyclor (Drug) $58.60
- CHANTIX (Drug) $54.53
- ELIQUIS (Drug) $48.83
- PRALUENT (Drug) $48.61
- PRALUENT ALIROCUMAB INJECTION (Biological) $45.44
- ENTRESTO (Drug) $27.77
- Repatha (Biological) $27.20
- Ozempic (Drug) $22.63
- VERQUVO (Drug) $21.70
- PRADAXA (Drug) $19.97
- Savaysa (Drug) $19.77
- Vascepa (Drug) $14.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in West Orange
Marc Roelke, M.d, M.D
Cardiovascular Disease — Payments: $273,645
Cardiovascular Disease $273,645
Fadi Chaaban, M.d, M.D
Cardiovascular Disease — Payments: $209,860
Cardiovascular Disease $209,860
Sabino Torre, M.d, M.D
Cardiovascular Disease — Payments: $115,814
Cardiovascular Disease $115,814
Abbas Shehadeh, Md, MD
Cardiovascular Disease — Payments: $65,125
Cardiovascular Disease $65,125
Constantinos Costeas, M.d, M.D
Cardiovascular Disease — Payments: $18,617
Cardiovascular Disease $18,617
Dr. Nicholas Tullo, Md, MD
Cardiovascular Disease — Payments: $14,213
Cardiovascular Disease $14,213